| Assessment Status | NCPE Assessment Process Complete |
| HTA ID | - |
| Drug | Apixaban |
| Brand | Eliquis® |
| Indication | For the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation. |
| Assessment Process | |
| Rapid review commissioned | 07/12/2012 |
| Rapid review completed | 21/12/2012 |
| Rapid review outcome | Full Pharmacoeconomic Evaluation Recommended |
| Full submission received from Applicant | 05/04/2013 |
| NCPE assessment completed | 31/05/2013 |
| NCPE assessment outcome | Reimbursement Recommended |